Paul Knight
Stock Analyst at Keybanc
(2.42)
# 2,555
Out of 5,042 analysts
139
Total ratings
47.83%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $282.07 | +24.08% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $11.67 | +28.53% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.19 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $116.01 | +89.64% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.24 | +62.34% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $113.85 | +18.58% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.52 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $62.57 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $349.60 | +31.58% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.20 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.98 | +168.46% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $93.59 | +54.93% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $170.54 | +146.28% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $81.50 | +182.21% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $27.87 | +18.41% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $25.50 | +41.18% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $215.38 | +43.93% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $149.06 | +47.59% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $567.39 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $25.22 | +46.71% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.13 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $5.25 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $146.36 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $30.19 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.82 | +238.41% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $180.07 | +66.60% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $216.46 | +15.49% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $124.47 | +254.30% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $120.09 | +96.52% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $69.91 | +41.61% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.11 | +395.05% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $36.08 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $71.89 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $123.54 | - | 5 | Oct 23, 2017 |
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $282.07
Upside: +24.08%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $11.67
Upside: +28.53%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.19
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $116.01
Upside: +89.64%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.24
Upside: +62.34%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $113.85
Upside: +18.58%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.52
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $62.57
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $349.60
Upside: +31.58%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.20
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.98
Upside: +168.46%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $93.59
Upside: +54.93%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $170.54
Upside: +146.28%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $81.50
Upside: +182.21%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $27.87
Upside: +18.41%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $25.50
Upside: +41.18%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $215.38
Upside: +43.93%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $149.06
Upside: +47.59%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $567.39
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $25.22
Upside: +46.71%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.13
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $5.25
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $146.36
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $30.19
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.82
Upside: +238.41%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $180.07
Upside: +66.60%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $216.46
Upside: +15.49%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $124.47
Upside: +254.30%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $120.09
Upside: +96.52%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $69.91
Upside: +41.61%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.11
Upside: +395.05%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $36.08
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $71.89
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $123.54
Upside: -